Beijing Science Sun Pharmaceutical Co Ltd (300485) — Strategic Asset Allocation Index
Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Strategic Asset Allocation Index of 15.4% as of June 2023. Strategic assets (PP&E of CN¥556.37 Million plus long-term investments of CN¥-) total CN¥556.37 Million, measured against net assets of CN¥3.62 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Beijing Science Sun Pharmaceutical Co Lt liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Beijing Science Sun Pharmaceutical Co Ltd Strategic Asset Allocation Index (2012–2022)
This chart shows how Beijing Science Sun Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 15.4%, representing strategic assets of CN¥556.37 Million against net assets of CN¥3.62 Billion CNY. See Beijing Science Sun Pharmaceutical Co Lt free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Beijing Science Sun Pharmaceutical Co Ltd (2012–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Beijing Science Sun Pharmaceutical Co Ltd from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 300485 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 16.8% | CN¥572.18 Million | CN¥572.18 Million | CN¥- | CN¥3.41 Billion | ▼ -1.5 pp |
| 2021 | 18.2% | CN¥598.90 Million | CN¥598.90 Million | CN¥- | CN¥3.28 Billion | ▼ -3.5 pp |
| 2020 | 21.7% | CN¥619.70 Million | CN¥619.70 Million | CN¥- | CN¥2.85 Billion | ▲ +0.9 pp |
| 2019 | 20.8% | CN¥564.01 Million | CN¥564.01 Million | CN¥- | CN¥2.71 Billion | ▼ -7.4 pp |
| 2018 | 28.2% | CN¥721.14 Million | CN¥459.11 Million | CN¥262.03 Million | CN¥2.56 Billion | ▲ +4.3 pp |
| 2017 | 23.9% | CN¥554.34 Million | CN¥323.68 Million | CN¥230.66 Million | CN¥2.32 Billion | ▲ +3.5 pp |
| 2016 | 20.4% | CN¥428.18 Million | CN¥218.08 Million | CN¥210.09 Million | CN¥2.10 Billion | ▲ +9.0 pp |
| 2015 | 11.4% | CN¥213.90 Million | CN¥108.90 Million | CN¥105.00 Million | CN¥1.88 Billion | ▼ -5.4 pp |
| 2014 | 16.7% | CN¥108.31 Million | CN¥108.31 Million | CN¥- | CN¥646.64 Million | ▼ -6.7 pp |
| 2013 | 23.5% | CN¥115.91 Million | CN¥115.91 Million | CN¥- | CN¥493.71 Million | ▼ -5.5 pp |
| 2012 | 29.0% | CN¥104.44 Million | CN¥104.44 Million | CN¥- | CN¥359.96 Million | — |